Euclidean Capital LLC
- SEC CIK
- 0001825034
- Latest filing
- Aug 14, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 14, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 11
- 0 vs. Q1 2025
- Portfolio value
- $305.7M
- +$39.6M (+14.9%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Vanguard Ftse All-World Ex-US Index Fund922042775 | ETF | 2,142,684 | $144.0M | 47.1% | +150,800+7.6% | Added | – |
| iShares MSCI India ETF46429B598 | ETF | 2,425,144 | $135.0M | 44.2% | 00.0% | Unchanged | – |
| ORICOric Pharmaceuticals, Inc. | COM | 989,410 | $10.0M | 3.3% | 00.0% | Unchanged | History |
| FHTXFoghorn Therapeutics Inc. | COM | 1,573,761 | $7.40M | 2.4% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 2,627,643 | $2.79M | 0.9% | 00.0% | Unchanged | History |
| SPYSPDR S&P 500 ETF Trust | ETF | 4,104 | $2.54M | 0.8% | 00.0% | Unchanged | History |
| ALECAlector, Inc. | COM | 1,307,858 | $1.83M | 0.6% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM NEW | 87,696 | $784.0K | 0.3% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM NEW | 82,234 | $657.9K | 0.2% | +82,234 | New | History |
| TNYATenaya Therapeutics, Inc. | COM | 1,015,705 | $620.8K | 0.2% | 00.0% | Unchanged | History |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 170,833 | $3.09K | <0.1% | 00.0% | Unchanged | – |
Sold out since Q1 2025 (1)
Positions held at the end of Q1 2025 that are gone from this filing.